A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2004
12/29/2004	EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490095A1 Stable pharmaceutical composition containing factor viii
12/29/2004	EP1490072A1 Novel therapeutical use of agonist ligands specific to g2a receptor
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1490056A1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
12/29/2004	EP1490048A1 Pharmaceutical composition for preventing or treating respiratory disease
12/29/2004	EP1490044A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
12/29/2004	EP1373259B1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment
12/29/2004	EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/29/2004	EP1255821B1 Protein c derivatives
12/29/2004	EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004	EP1198242A4 Autologous thrombin
12/29/2004	EP1123274B1 Substituted phenyl derivatives, their preparation and use
12/29/2004	EP1117643B1 New crystal modification n of torasemide
12/29/2004	EP1071768B1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
12/29/2004	EP1032560B1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	CN1558952A Pegylated and diglycosylated erythropoietin
12/29/2004	CN1558911A Synthetic heparin pentasaccharides
12/29/2004	CN1558894A Method for the nitration of phenolic compounds
12/29/2004	CN1558767A A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof
12/29/2004	CN1557476A Multiple biological activity polypeptide nutrient
12/29/2004	CN1557466A Marrow peptide preparation and its preparing process
12/29/2004	CN1557455A Powder injection of ginko and dipyridamole and its preparing method
12/29/2004	CN1557421A Medicine for treating cerebral thrombus and its preparing process
12/29/2004	CN1557390A Chinese traditional medicine for treating thrombocytopenia
12/29/2004	CN1557363A Chinese medicinal composition for treating internal hemorrhage
12/29/2004	CN1557306A Flavescent sophora root essence dispersion tablet
12/29/2004	CN1557302A Carbazochrome Sodium Sulfonate infusion and its preparation method
12/29/2004	CN1557296A Gingko lactone freeze dried powder injection and its preparation method
12/29/2004	CN1182247C Sequence-specific DNA recombination in eukaryotic cells
12/29/2004	CN1182121C Compound with activity for resisting platelet aggregation and its preparation method
12/29/2004	CN1181886C Application of TNF-derived peptides in the treatment of oedema
12/29/2004	CN1181874C Medicine for treating acute cerebral hemorrhage and its preparing method
12/29/2004	CA2525713A1 Benzofuran inhibitors of factor viia
12/28/2004	US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis
12/28/2004	US6835817 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
12/28/2004	US6835809 Thrombopoietic compounds
12/28/2004	US6835808 Anti-heparin peptides
12/28/2004	US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835751 Bicyclic amino acids as pharmaceutical agents
12/28/2004	US6835739 Benzamides and related inhibitors of factor Xa
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835401 Method of treating diseases caused by over-production of free-radicals
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/23/2004	WO2004110997A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa
12/23/2004	WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE
12/23/2004	WO2004110469A2 Formulations comprising factor viia and a factor vii related polypeptide
12/23/2004	WO2004110449A1 Aporphine and oxoaporphine and the medical use thereof
12/23/2004	WO2004110435A1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
12/23/2004	WO2004110434A1 2-pyrrolidone derivatives and use thereof as factor xa inhibitors
12/23/2004	WO2004110433A1 Pyrrolidin-1, 2- dicarboxylic acid- 1- [(4- ethinyl- phenyl) - amid]- 2- [(phenyl)- amid] derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis
12/23/2004	WO2004049095A3 Betaine and salicylic acid compositions
12/23/2004	WO2004045563A3 Method of treatment of myocardial infarction
12/23/2004	US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents
12/23/2004	US20040259865 Laxative; adenosine receptor antagonist
12/23/2004	US20040259864 Substituted pyrimidinone derivatives as ligands of integrin receptors
12/23/2004	US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259799 Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259780 Method for treating diabetes and obesity
12/23/2004	US20040259769 Hemoglobulin for oxygen delivery; cardiovascular disorders; gastrointestinal disorders
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040258745 Pharmaceutical composition containing artificial oxygen carrier
12/23/2004	US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	US20040258619 Diaminedioxime radiometal complexes
12/23/2004	DE10325962A1 Aroylsemicarbazidderivate Aroylsemicarbazidderivate
12/23/2004	DE10325049A1 New peptide derivatives containing cell-adhesion molecule and phosphonate-containing anchor component, useful for treating disorders associated with implants, are inhibitors of integrins
12/23/2004	DE10235248B4 Fusionsprotein mit verstärkter in vivo-Aktivität von Erythropoietin Fusion protein with enhanced in vivo activity of erythropoietin
12/23/2004	CA2531406A1 Aporphine and oxoaporphine and the medical use thereof
12/23/2004	CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases
12/22/2004	EP1489171A1 Functional molecule and process for producing the same
12/22/2004	EP1489097A1 Inhibitors of human plasmin derived from kunitz domains and nucleic acids encoding the same
12/22/2004	EP1489096A1 Novel hemepeptide
12/22/2004	EP1489088A1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative
12/22/2004	EP1489078A1 Benzofuran derivative
12/22/2004	EP1488808A1 Remedies for glomerular diseases
12/22/2004	EP1488806A2 A blocking monoclonal antibody to VLA-1 and its use for the treatment of vascular disorders
12/22/2004	EP1488800A1 Agent for the treatment of protozoal diseases
12/22/2004	EP1488790A1 Solid preparation containing single crystal form
12/22/2004	EP1487992A2 Central airway administration for systemic delivery of therapeutics
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487826A1 New crystalline forms of (2s)-n-5- amino(imino)methyl -thienylmethyl-1-(2r)-2- (carboxymethyl)amino -3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487792A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols

1 ... 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 ... 671